A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2003
published in
- Experimental neurology Journal
has subject area
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- Adenosine A2 Receptor Antagonists
- Animals
- Antiparkinson Agents
- Apomorphine
- Denervation
- Dopamine Agonists
- Dyskinesia, Drug-Induced
- Levodopa
- Macaca fascicularis
- Male
- Neurons
- Oxidopamine
- Parkinson Disease, Secondary
- Phosphorylation
- Purines
- Rats
- Rats, Sprague-Dawley
- Receptors, AMPA
- Receptors, Dopamine D1
- Receptors, Dopamine D2
- Sympatholytics